These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7114776)

  • 1. Oestrogen receptor analysis in early cancer of the breast.
    Missotten F
    Ann R Coll Surg Engl; 1982 Sep; 64(5):353-4. PubMed ID: 7114776
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oestrogen receptors and prognosis in breast cancer].
    Rainer H; Bettelheim P; Bieglmayer C; Chaput B; Jakesz R; Kees A; Kolb R; Mörz R; Moser K; Reiner G; Schemper M; Spona J
    Wien Klin Wochenschr; 1980 Nov; 92(22):796-803. PubMed ID: 7467359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of oestrogen receptor beta in breast cancer.
    Palmieri C
    Br J Surg; 2000 Sep; 87(9):1248-9. PubMed ID: 10971439
    [No Abstract]   [Full Text] [Related]  

  • 4. Oestrogen receptor beta in breast cancer: good, bad or still too early to tell?
    Speirs V
    J Pathol; 2002 Jun; 197(2):143-7. PubMed ID: 12015736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen receptors in human breast cancer [proceedings].
    De Boever J; Vandekerckhove D
    Arch Int Physiol Biochim; 1980 Feb; 88(1):B24-B26. PubMed ID: 6155841
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of oestrogen receptor beta in breast cancer.
    Speirs V; Kerin MJ
    Br J Surg; 2000 Apr; 87(4):405-9. PubMed ID: 10759732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific estrogen receptor binding and biological effects of 16 alpha-iodoestradiol on human breast cancer cells.
    Lippman ME; Do HM; Hochberg RB
    Cancer Res; 1981 Aug; 41(8):3150-4. PubMed ID: 7248972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables.
    Cross SS; Harrison RF; Balasubramanian SP; Lippitt JM; Evans CA; Reed MW; Holen I
    J Clin Pathol; 2006 Jul; 59(7):716-20. PubMed ID: 16489180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen receptor status of breast carcinoma: Allred/H score conversion table.
    Shousha S
    Histopathology; 2008 Sep; 53(3):346-7. PubMed ID: 18631198
    [No Abstract]   [Full Text] [Related]  

  • 10. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.
    Pietras RJ; Arboleda J; Reese DM; Wongvipat N; Pegram MD; Ramos L; Gorman CM; Parker MG; Sliwkowski MX; Slamon DJ
    Oncogene; 1995 Jun; 10(12):2435-46. PubMed ID: 7784095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen receptor beta: how should we measure this?
    Speirs V; Carder PJ; Lansdown MR
    Br J Cancer; 2002 Sep; 87(6):687; author reply 688-9. PubMed ID: 12237781
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of estrogen receptors in mammary carcinomas. Is immunocytochemical determination after formalin fixation sufficient?].
    Haugen OA; Aasmundstad T; Johannesen E; Ytterhus B; Nervik I
    Tidsskr Nor Laegeforen; 1993 Mar; 113(8):944-6. PubMed ID: 8470071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estrogen receptors and breast cancer].
    Maudelonde T; Pujol P; Rochefort H
    Rev Prat; 1994 May; 44(10):1299-303. PubMed ID: 7939188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
    Francis G; Beadle G; Thomas S; Mengersen K; Stein S
    Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
    Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?
    Rhodes A; Jasani B
    J Clin Pathol; 2009 Jan; 62(1):95-6. PubMed ID: 19103868
    [No Abstract]   [Full Text] [Related]  

  • 18. Oestrogen causes G2/M arrest and apoptosis in breast cancer cells MDA-MB-231.
    Nomoto S; Arao Y; Horiguchi H; Ikeda K; Kayama F
    Oncol Rep; 2002; 9(4):773-6. PubMed ID: 12066207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA; Thompson LU
    Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer.
    McCarthy K; Bustin SA; Ogunkolade B; Khalaf S; Laban CA; McVittie CJ; Carpenter R; Jenkins PJ
    Eur J Surg Oncol; 2006 Sep; 32(7):707-9. PubMed ID: 16650963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.